Clinical Trials Directory

Trials / Completed

CompletedNCT01373255

Balloon Catheters in Cases of Abnormal Placentation

Balloon Catheter for Occlusion of the Pelvic Vasculature as an Adjuvant Therapy in Cases of Placenta Accreta

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
HaEmek Medical Center, Israel · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Placenta accreta is a relatively rare event, in which the placenta is abnormally implanted into the uterine myometrium. The most significant complication is intense bleeding, mainly during labor. The most important risk factors are previous cesarean delivery, placenta previa, and advanced maternal age. Cesarean hysterectomy is the recommended management. During the recent years, inserting intravascular balloon catheter for occlusion and/or arterial embolization, was introduced as an adjuvant therapy in order to minimize blood loss during cesarean hysterectomy or in conduct with conservative management with the intent of avoiding hysterectomy in selective cases. Contradicting reports exist regarding the effectiveness and safety of the catheters in cases of placenta accreta. The objective of this study is to estimate the efficacy of the balloon catheters among women diagnosed with a placenta accreta.

Conditions

Interventions

TypeNameDescription
PROCEDUREinternal iliac catheterizationWomen in this arm will undergo internal iliac artery catheterization prior to the cesarean delivery

Timeline

Start date
2009-01-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2011-06-14
Last updated
2015-06-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01373255. Inclusion in this directory is not an endorsement.